West Branch Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.21K Hold
97
﹤0.01% 264
2026
Q1
$6.91K Hold
97
﹤0.01% 254
2025
Q4
$7.96K Sell
97
-14
-13% -$1.09K ﹤0.01% 281
2025
Q3
$8.34K Hold
111
﹤0.01% 295
2025
Q2
$8.22K Buy
111
+27
+32% +$1.88K ﹤0.01% 295
2025
Q1
$6.78K Hold
84
﹤0.01% 321
2024
Q4
$6.57K Hold
84
﹤0.01% 315
2024
Q3
$7.88K Buy
84
+1
+1% +$84 ﹤0.01% 295
2024
Q2
$6.47K Hold
83
﹤0.01% 311
2024
Q1
$7.55K Hold
83
﹤0.01% 298
2023
Q4
$6.42K Hold
83
﹤0.01% 314
2023
Q3
$5.65K Hold
83
﹤0.01% 325
2023
Q2
$6.74K Sell
83
-6
-7% -$479 ﹤0.01% 315
2023
Q1
$7.3K Buy
+89
New +$6.36K ﹤0.01% 313

Other funds holding GEHC

West Branch Capital's GEHC Position: Q2 2026 in Review

West Branch Capital held its GE HealthCare (GEHC) position steady in Q2 2026 at 97 shares worth $6.21K. The position accounts for ﹤0.01% of the portfolio, ranked #264.

West Branch Capital first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $8.34K in Q3 2025. 280 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • West Branch Capital held 97 shares of GE HealthCare worth $6.21K as of Q2 2026.
  • West Branch Capital left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up ﹤0.01% of West Branch Capital's portfolio in Q2 2026, its #264 holding.
  • West Branch Capital first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • West Branch Capital's GE HealthCare position peaked at $8.34K in Q3 2025.
  • 280 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.